Got 90 seconds? Then listen to Edison Investment Research managing partner Maxim Jacobs discuss the medicinal cannabis sector and MGC Pharmaceuticals.

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac.

The company produces sponsored research on over 400 companies across a broad range of sectors and market caps.

Edison recently completed a research report on MGC Pharmaceuticals (ASX:MXC).

MGC is a global biopharma company focused on developing and supplying high-quality phytotherapeutics and phytomedicines to patients in Europe, Australasia, and North America.

Stockhead gave Edison’s managing partner Maxim Jacobs 90 seconds to tell us more about the medicinal cannabis sector and the key findings from the report.

Have a good idea for our next 90 Seconds With… segment? Email us at tv@stockhead.com.au.